Clinical Trial Update: Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating liraglutide in subjects with liver impairment compared with those with normal liver function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)
• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED